FCA
ABBV icon

FinTrust Capital Advisors’s AbbVie ABBV Stock Holding History

FinTrust Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.45M Sell
12,393
-37
-0.3% -$6.91K 0.41% 49
2024
Q2 		$2.13M Buy
12,430
+666
+6% +$110K 0.39% 51
2024
Q1 		$2.14M Buy
11,764
+225
+2% +$38.8K 0.41% 49
2023
Q4 		$1.79M Sell
11,539
-177
-2% -$25.8K 0.36% 57
2023
Q3 		$1.75M Buy
11,716
+958
+9% +$141K 0.39% 53
2023
Q2 		$1.74M Hold
10,758
– – 0.42% 58
2023
Q1 		$1.74M Hold
10,758
– – 0.42% 59
2022
Q4 		$1.74M Sell
10,758
-223
-2% -$34.2K 0.42% 60
2022
Q3 		$1.59M Buy
10,981
+656
+6% +$94.1K 0.41% 59
2022
Q2 		$1.53M Buy
10,325
+485
+5% +$74.1K 0.38% 63
2022
Q1 		$1.59M Buy
9,840
+1,681
+21% +$244K 0.37% 66
2021
Q4 		$1.1M Buy
8,159
+4,041
+98% +$477K 0.26% 80
2021
Q3 		$444K Buy
4,118
+35
+0.9% +$4K 0.12% 156
2021
Q2 		$460K Buy
4,083
+104
+3% +$11.7K 0.12% 151
2021
Q1 		$431K Sell
3,979
-8
-0.2% -$856 0.12% 150
2020
Q4 		$427K Sell
3,987
-753
-16% -$72.4K 0.14% 138
2020
Q3 		$415 Sell
4,740
-1,325
-22% -$125K 0.08% 137
2020
Q2 		$595K Sell
6,065
-817
-12% -$71.9K 0.24% 86
2020
Q1 		$524K Sell
6,882
-1,264
-16% -$108K 0.25% 85
2019
Q4 		$721K Sell
8,146
-175
-2% -$14.5K 0.29% 72
2019
Q3 		$630K Sell
8,321
-1,312
-14% -$90K 0.22% 100
2019
Q2 		$701K Sell
9,633
-41
-0.4% -$3.22K 0.28% 71
2019
Q1 		$779K Buy
9,674
+366
+4% +$29.9K 0.33% 57
2018
Q4 		$858K Buy
+9,308
New +$819K 0.42% 49

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

FinTrust Capital Advisors's ABBV Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its AbbVie (ABBV) stake by 0.3% in Q3 2024, selling an estimated $6.91K and leaving 12,393 shares worth $2.45M. The position accounts for 0.41% of the portfolio, ranked #49.

FinTrust Capital Advisors first reported a position in ABBV in Q4 2018 and has held it in 24 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • FinTrust Capital Advisors held 12,393 shares of AbbVie worth $2.45M as of Q3 2024.
  • FinTrust Capital Advisors sold 37 AbbVie shares in Q3 2024, an estimated $6.91K.
  • AbbVie made up 0.41% of FinTrust Capital Advisors's portfolio in Q3 2024, its #49 holding.
  • FinTrust Capital Advisors first reported a position in AbbVie in Q4 2018 and has held it in 24 quarters since.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.